Warning: There are an increasing number of fraudulent websites that impersonate the ECCMID. We would like to alert all our members and delegates to be aware of possible scams and to strongly advise you to only use the official ECCMID online registration and accommodation services for your bookings.

Abstract Topics

Abstracts can be submitted from 4 September to 30 November 2017


To download the abstract guidelines and abstract topics in pdf version – please click here.


1 Viral Infection & Disease

a. HIV/AIDS (incl anti-retroviral drugs, treatment & susceptibility/resistance, diagnostics & epidemiology) OR (all aspects)

b. Viral hepatitis (incl antiviral drugs, treatment & susceptibility/resistance, diagnostics & epidemiology) OR (all aspects)

c. Influenza and respiratory viruses

d. Emerging/re-emerging and zoonotic viral diseases

e. Antiviral drugs, treatment, susceptibility/resistance (other than hepatitis & HIV)

f. Viral molecular epidemiology (other than hepatitis & HIV)

g. Diagnostic virology (other than hepatitis & HIV)


2 Bacterial Infection & Disease

a. Tuberculosis and other mycobacterial infections

b. Severe sepsis, bacteraemia & endocarditis

c. Community-acquired respiratory infections

d. Abdominal/gastrointestinal, urinary tract & genital infections

e. Skin, soft tissue, bone & joint & central nervous system infections

f. Zoonotic bacterial diseases


3 Bacterial Susceptibility & Resistance

a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives

b. Resistance surveillance & epidemiology: Gram-negatives

c. Susceptibility testing methods

d. Resistance mechanisms


4 Diagnostic Bacteriology & General Microbiology

a. Diagnostic bacteriology – culture based

b. Diagnostic bacteriology – non-culture based, including molecular and MALDI-TOF

c. Molecular bacterial typing methods

d. Laboratory automation

e. General microbiology


5 New Antibacterial Agents, PK/PD & Stewardship

a. Mechanisms of action, preclinical data & pharmacology of antibacterial agents

b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring

c. New antibacterial agents: clinical trials

d. Pharmacoepidemiology, improved prescribing and antibiotic stewardship


6 Fungal Infection & Disease

a. Fungal disease epidemiology & clinical trials

b. Diagnostic mycology (incl molecular)

c. Antifungal drugs & treatment

d. Antifungal resistance & susceptibility testing


7 Parasitic Diseases & International Health

a. Diagnostic parasitology

b. Antiparasitic susceptibility & resistance

c. Antiparasitic drugs & treatment

d. Parasitic disease epidemiology

e. Travel medicine & migrant health

f. International & public health


8 Healthcare-associated & Nosocomial Infections, Infection Control

a. Intravascular catheter-related infections

b. Other foreign-body and implant infections

c. Surgical site infections

d. Nosocomial infection surveillance & epidemiology

e. Infection control interventional trials

f. Disinfection & biocides


9 Experimental Microbiology, Microbial Pathogenesis & Biofilm

a. Microbial pathogenesis & virulence

b. Host-pathogen interaction

c. Preclinical biofilm studies

d. Experimental and cellular microbiology


10 Immunology & Vaccinology

a. Host genetics: infection susceptibility & immunodeficiency

b. Clinical epidemiology of infections in immunocompromised hosts

c. General vaccinology

d. Antiviral vaccines

e. Antibacterial vaccines


11 Other